tradingkey.logo

WGRX

WGRX
查看详细走势图
0.486USD
+0.007+1.42%
收盘 12/19, 16:00美东报价延迟15分钟
43.45M总市值
亏损市盈率 TTM

WGRX

0.486
+0.007+1.42%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.42%

5天

-15.16%

1月

-0.59%

6月

-59.86%

今年开始到现在

0.00%

1年

0.00%

查看详细走势图

TradingKey WGRX股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Wellgistics Health Inc当前公司基本面数据相对稳定,增长潜力稳定。当前估值合理,在医疗设备与耗材行业排名161/208位。机构持股占比非常高,中期看,股价处于下降通道。近一个月,市场表现一般,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

WGRX评分

相关信息

行业排名
161 / 208
全市场排名
480 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

WGRX亮点

亮点风险
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
业绩增长期
公司处于发展阶段,最新年度总收入18.13M美元
利润高增长
公司净利润处于行业前列,最新年度总收入18.13M美元
估值高估
公司最新PE估值-0.38,处于3年历史高位
机构加仓
最新机构持股1.68M股,环比增加43.54%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00

WGRX新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

WGRX简介

Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
公司代码WGRX
公司Wellgistics Health Inc
CEOMr. Brian Norton
网址https://wellgisticshealth.com/

常见问题

WGRX(WGRX)的当前股价是多少?

WGRX(WGRX)的当前股价是 0.486。

WGRX的股票代码是什么?

WGRX的股票代码是WGRX。

WGRX股票的52周最高点是多少?

WGRX股票的52周最高点是7.040。

WGRX股票的52周最低点是多少?

WGRX股票的52周最低点是0.336。

WGRX的市值是多少?

WGRX的市值是43.45M。

WGRX的净利润是多少?

WGRX的净利润为-6.86M。

现在WGRX(WGRX)的股票是买入、持有还是卖出?

根据分析师评级,WGRX(WGRX)的总体评级为--,目标价格为--。

WGRX(WGRX)股票的每股收益(EPS TTM)是多少

WGRX(WGRX)股票的每股收益(EPS TTM)是-1.272。
KeyAI